Urticaria highlights from AAD 2025 include late-breaking results from a phase 1b/2a study of the anti-c-Kit antibody ...

Adults with chronic spontaneous urticaria experienced greater mortality, probably due to increased risks for comorbidities, ...

The following is a summary of “Patient and physician perspectives on disease burden in chronic spontaneous urticaria,” ...

Chronic pain is defined as pain that persists beyond acute pain, typically over six months. It can be initiated with an injury or disease, but may persist after the triggering injury has healed ...

Telangana: Drugs Control Administration, Telangana, has seized Spurious Drugs (Counterfeit Versions) 'Montek-LC' Tablets ...

The cause of chronic hives is usually unknown. Studies suggest that between 80% and 90% of cases are idiopathic. Even with extensive diagnostics, a cause may never be found. Dermatographism is a form ...

For patients with symptomatic chronic spontaneous urticaria after treatment with second-generation H 1-antihistamines, administration of the oral, highly selective Bruton's tyrosine kinase ...

Medically reviewed by Lindsay Cook, PharmD Xyzal (levocetirizine) and Zyrtec (cetirizine) are antihistamines taken to relieve allergy symptoms such as sneezing, runny nose, itchy eyes, and hives.

Remibrutinib, an oral Bruton’s tyrosine kinase inhibitor, reduced itch and hives in patients with chronic spontaneous urticaria and showed a favorable safety profile at week 12 in two trials.

Chronic stress is a common risk factor for stroke, but may not affect everyone the same way. Stress is inherently subjective. For some people, stress could be caused by an important work deadline ...

Phase III REMIX-1 and REMIX-2 trials demonstrated that remibrutinib, an oral BTK inhibitor, significantly reduced chronic spontaneous urticaria symptoms in patients unresponsive to second-generation ...